Shared mechanisms of organ fibrosis
JCI Insight · 08.07.2026 · 11 (13)
DOI: 10.1172/jci.insight.200952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JCI Insight, online erschienen am 08.07.2026. Verfasst von Benjamin D Humphreys. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, and. Hauptthemen laut MEDLINE: Fibrosis, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Organ fibrosis involves a complex interplay between diverse cell types and signaling pathways that ultimately leads to the pathologic accumulation of excessive extracellular matrix, subsequently resulting in organ dysfunction. In recent years, the first drugs for the treatment of idiopathic pulmonary fibrosis have been approved; however, there is a major unmet need for effective antifibrotic therapies across organs. Despite the complexity of the fibrotic process in different tissues, certain features are shared and may form the basis for future therapeutic strategies. This Review will highlight these shared characteristics, cell states, and signaling pathways across organs with the goal of highlighting potential antifibrotic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, and.
- Department of Developmental Biology, Washington University in St. Louis, St. Louis, Missouri, USA.
Zitieren
APA
Humphreys, B. D. (2026). Shared mechanisms of organ fibrosis. JCI Insight, 11(13). https://doi.org/10.1172/jci.insight.200952
Vancouver
Humphreys BD. Shared mechanisms of organ fibrosis. JCI Insight. 2026;11(13). doi:10.1172/jci.insight.200952
BibTeX
@article{Humphreys2026,
author = {Humphreys, Benjamin D},
title = {Shared mechanisms of organ fibrosis},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {13},
doi = {10.1172/jci.insight.200952}
}
EUVIMED